IMPROVED ADJUVANT THERAPY OF G250-EXPRESSING TUMORS
摘要
The invention relates to a method for the treatment of G250-antigen-expressing tumors, in particular renal clear cell carcinoma comprising the administration of G250-antigen-specific antibodies to high-risk patients diagnosed with non-metastasising disease.